These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 37629096)

  • 21. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
    Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
    Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
    Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma.
    Guo Z; Xie Y; Zhang L; Liu S; Jiang W
    Aging (Albany NY); 2024 Jan; 16(1):267-284. PubMed ID: 38180745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis and chemotherapy drug sensitivity in liver hepatocellular carcinoma through a disulfidptosis-related lncRNA signature.
    Chen C; Wang C; Li Y; Jiang S; Yu N; Zhou G
    Sci Rep; 2024 Mar; 14(1):7157. PubMed ID: 38531953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A disulfidptosis-related lncRNA index predicting prognosis and the tumor microenvironment in colorectal cancer.
    Xiao L; Yin W; Chen X; Zhang X; Zhang C; Yu Z; Lü M
    Sci Rep; 2023 Nov; 13(1):20135. PubMed ID: 37978247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma.
    Dai X; Zeng M; Huang Z; Zhang J; Wei Z; Wang Z
    Dis Markers; 2022; 2022():2823042. PubMed ID: 36393968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
    Tan Z; Fu S; Zuo J; Wang J; Wang H
    Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms.
    Chi H; Huang J; Yan Y; Jiang C; Zhang S; Chen H; Jiang L; Zhang J; Zhang Q; Yang G; Tian G
    Front Mol Biosci; 2023; 10():1254232. PubMed ID: 37916187
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 32. Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.
    Pan Y; Jin X; Xu H; Hong J; Li F; Luo T; Zeng J
    Sci Rep; 2024 Jun; 14(1):13113. PubMed ID: 38849442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer.
    Lin Y; Xiao Y; Liu S; Hong L; Shao L; Wu J
    BMC Med Genomics; 2022 Oct; 15(1):221. PubMed ID: 36280825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma.
    Pang Y; Wang Y; Zhou X; Ni Z; Chen W; Liu Y; Du W
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 36. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.
    Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z
    Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of disulfidptosis- and cuproptosis-related LncRNAs in modulating the immune microenvironment and chemosensitivity in colon adenocarcinoma.
    Fan Q; Wu GB; Chen M; Zheng L; Li HJ; Xiang LZ; Luo M
    IET Syst Biol; 2024 Apr; 18(2):55-75. PubMed ID: 38458989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma.
    Wang HL; Ye ZM; He ZY; Huang L; Liu ZH
    Hereditas; 2023 Feb; 160(1):6. PubMed ID: 36755298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.